FINANCIALS

NBIX Neurocrine Biosciences Inc 914475

Income Statement
Revenue	nbix-20240930	622,100,000
Net Income	nbix-20240930	129,800,000
Profit Margin		20.86%

Balance Sheet
Current Assets	1,876,600,000
Assets	3,535,000,000
Current Liabilities	429,700,000
Liabilities	816,100,000
Equity	2,718,900,000
Shares Out	100,976,000

Cash Flow Statement
Operating Cash Flow	352,900,000
Investing Cash Flow	-58,500,000

Market Analysis
Market Cap	12,287,288,650
Price	143.26
BVPS	26.93
PB	5.33
EPS	3.31
PE	36.74
PS	4.94
FCF	294,400,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view NBIX documents filed with the SEC.

NBIX Filings Clear

View A List of Tickers